Rigel Pharmaceuticals, Inc. (RIGL) is lower by Friday morning, with the stock declining -3.09% in pre-market trading to 1.57. RIGL's short-term technical score of 54 indicates that the stock has traded more bullishly over the last month than 54% of stocks on the market. In the Biotechnology industry, which ranks 119 out of 146 industries, Rigel Pharmaceuticals, Inc. ranks higher than 65% of stocks. Rigel Pharmaceuticals, Inc. has risen 20.90% over the past month, closing at $1.14 on July 22. During this period of time, the stock fell as low as $1.14 and as high as $1.76. RIGL has an average analyst recommendation of Buy. The company has an average price target of $2.39.
RIGL has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on RIGL!